Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.18 CHF | -0.35% | +2.19% | +5.18% |
12:32pm | Morphosys says takeover by Novartis on course after report of drug safety concern | RE |
04-26 | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.18% | 200B | |
+25.88% | 661B | |
+27.43% | 566B | |
-6.42% | 352B | |
+20.51% | 332B | |
+2.83% | 283B | |
+14.45% | 231B | |
-8.96% | 195B | |
-5.39% | 145B | |
-10.44% | 144B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis : Signs Development, Distribution Deal With BeiGene For Tislelizumab